The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis
Clinical trial NCT06958939 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06958939
- Sponsor
- Ting Chang, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-04-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.